FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965152316> ?p ?o ?g. }

• W1965152316 endingPage "13290" @default.
• W1965152316 startingPage "13285" @default.
• W1965152316 abstract "Proenkephalin and other prohormones require proteolytic processing at paired basic and monobasic residues for the biosynthesis of active neuropeptides. The novel “prohormone thiol protease” (PTP) has been proposed as a candidate proenkephalin processing enzyme for the production of [Met]enkephalin in chromaffin granules (Krieger, T. J., and Hook, V. Y. H.(1991) J. Biol. Chem. 266, 88376-8383). In this study, PTP was examined during elevation of cellular [Met]enkephalin by forskolin, a direct activator of adenylate cyclase that produces cAMP. Treatment of chromaffin cells with forskolin for 72 h increased enkephalin precursor cleaving activity (measured by following the conversion of the model substrate [35S-Met]preproenkephalin to trichloroacetic acid-soluble radioactivity) in isolated chromaffin granules by 170-180% over controls (100%). The increased activity was associated with the membrane fraction, rather than the soluble fraction, of chromaffin granules. The elevated activity was inhibited by E-64c, which is a potent inhibitor of PTP and cysteine proteases; however, the activity was not inhibited by serine or aspartic protease inhibitors. The elevated activity was identified as PTP based on immunoprecipitation by anti-PTP immunoglobulins. Stimulation of PTP synthesis was involved in the forskolin-induced increase in PTP activity, as demonstrated by a 10-fold increase in [35S]PTP pulse labeling in forskolin-treated chromaffin cells. Forskolin elevation of PTP protein levels within chromaffin granules was also detected in Western blots. Importantly, the forskolin-mediated rise in cellular [Met]enkephalin levels was completely blocked when cells were preincubated with the cysteine protease inhibitor Ep453, which is known to be converted by intracellular esterases to the more effective inhibitor E-64c (Buttle, D. J., Saklatvala, J., Tamai, M., and Barrett, A. J.(1992) Biochem. J. 281, 175-177). Both E-64c and Ep453 inhibit PTP, with E-64c being more potent (Azaryan, A. V., and Hook, V. Y. H. (1994b) Arch. Biochem. Biophys. 314, 171-177). These results demonstrate a role for PTP in proenkephalin processing in chromaffin cells and indicate that [Met]enkephalin formation and PTP are both regulated by cAMP. Proenkephalin and other prohormones require proteolytic processing at paired basic and monobasic residues for the biosynthesis of active neuropeptides. The novel “prohormone thiol protease” (PTP) has been proposed as a candidate proenkephalin processing enzyme for the production of [Met]enkephalin in chromaffin granules (Krieger, T. J., and Hook, V. Y. H.(1991) J. Biol. Chem. 266, 88376-8383). In this study, PTP was examined during elevation of cellular [Met]enkephalin by forskolin, a direct activator of adenylate cyclase that produces cAMP. Treatment of chromaffin cells with forskolin for 72 h increased enkephalin precursor cleaving activity (measured by following the conversion of the model substrate [35S-Met]preproenkephalin to trichloroacetic acid-soluble radioactivity) in isolated chromaffin granules by 170-180% over controls (100%). The increased activity was associated with the membrane fraction, rather than the soluble fraction, of chromaffin granules. The elevated activity was inhibited by E-64c, which is a potent inhibitor of PTP and cysteine proteases; however, the activity was not inhibited by serine or aspartic protease inhibitors. The elevated activity was identified as PTP based on immunoprecipitation by anti-PTP immunoglobulins. Stimulation of PTP synthesis was involved in the forskolin-induced increase in PTP activity, as demonstrated by a 10-fold increase in [35S]PTP pulse labeling in forskolin-treated chromaffin cells. Forskolin elevation of PTP protein levels within chromaffin granules was also detected in Western blots. Importantly, the forskolin-mediated rise in cellular [Met]enkephalin levels was completely blocked when cells were preincubated with the cysteine protease inhibitor Ep453, which is known to be converted by intracellular esterases to the more effective inhibitor E-64c (Buttle, D. J., Saklatvala, J., Tamai, M., and Barrett, A. J.(1992) Biochem. J. 281, 175-177). Both E-64c and Ep453 inhibit PTP, with E-64c being more potent (Azaryan, A. V., and Hook, V. Y. H. (1994b) Arch. Biochem. Biophys. 314, 171-177). These results demonstrate a role for PTP in proenkephalin processing in chromaffin cells and indicate that [Met]enkephalin formation and PTP are both regulated by cAMP." @default.
• W1965152316 created "2016-06-24" @default.
• W1965152316 creator A5006603853 @default.
• W1965152316 creator A5036749356 @default.
• W1965152316 creator A5039107536 @default.
• W1965152316 creator A5073695837 @default.
• W1965152316 creator A5075467879 @default.
• W1965152316 creator A5088156165 @default.
• W1965152316 date "1995-06-01" @default.
• W1965152316 modified "2023-09-30" @default.
• W1965152316 title "Stimulation of “Prohormone Thiol Protease” (PTP) and [Met]Enkephalin by Forskolin." @default.
• W1965152316 cites W1215858103 @default.
• W1965152316 cites W1263658822 @default.
• W1965152316 cites W1497805203 @default.
• W1965152316 cites W1526778147 @default.
• W1965152316 cites W1529166175 @default.
• W1965152316 cites W1529469385 @default.
• W1965152316 cites W1558566725 @default.
• W1965152316 cites W1559409164 @default.
• W1965152316 cites W1572740290 @default.
• W1965152316 cites W1836307744 @default.
• W1965152316 cites W2012169503 @default.
• W1965152316 cites W2012427429 @default.
• W1965152316 cites W2012660426 @default.
• W1965152316 cites W2013950353 @default.
• W1965152316 cites W2014203128 @default.
• W1965152316 cites W2030901391 @default.
• W1965152316 cites W2036801607 @default.
• W1965152316 cites W2039518218 @default.
• W1965152316 cites W2040887234 @default.
• W1965152316 cites W2050694830 @default.
• W1965152316 cites W2067388503 @default.
• W1965152316 cites W2086517187 @default.
• W1965152316 cites W2128062280 @default.
• W1965152316 cites W2134939519 @default.
• W1965152316 cites W2175970545 @default.
• W1965152316 cites W72643761 @default.
• W1965152316 doi "https://doi.org/10.1074/jbc.270.22.13285" @default.
• W1965152316 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7768928" @default.
• W1965152316 hasPublicationYear "1995" @default.
• W1965152316 type Work @default.
• W1965152316 sameAs 1965152316 @default.
• W1965152316 citedByCount "21" @default.
• W1965152316 crossrefType "journal-article" @default.
• W1965152316 hasAuthorship W1965152316A5006603853 @default.
• W1965152316 hasAuthorship W1965152316A5036749356 @default.
• W1965152316 hasAuthorship W1965152316A5039107536 @default.
• W1965152316 hasAuthorship W1965152316A5073695837 @default.
• W1965152316 hasAuthorship W1965152316A5075467879 @default.
• W1965152316 hasAuthorship W1965152316A5088156165 @default.
• W1965152316 hasBestOaLocation W19651523161 @default.
• W1965152316 hasConcept C126322002 @default.
• W1965152316 hasConcept C134018914 @default.
• W1965152316 hasConcept C170493617 @default.
• W1965152316 hasConcept C181199279 @default.
• W1965152316 hasConcept C182220744 @default.
• W1965152316 hasConcept C185592680 @default.
• W1965152316 hasConcept C24998067 @default.
• W1965152316 hasConcept C2775894120 @default.
• W1965152316 hasConcept C2777515746 @default.
• W1965152316 hasConcept C2777597313 @default.
• W1965152316 hasConcept C2777803847 @default.
• W1965152316 hasConcept C2779276759 @default.
• W1965152316 hasConcept C2780090379 @default.
• W1965152316 hasConcept C2780910648 @default.
• W1965152316 hasConcept C2781063702 @default.
• W1965152316 hasConcept C55493867 @default.
• W1965152316 hasConcept C71315377 @default.
• W1965152316 hasConcept C71924100 @default.
• W1965152316 hasConcept C86803240 @default.
• W1965152316 hasConceptScore W1965152316C126322002 @default.
• W1965152316 hasConceptScore W1965152316C134018914 @default.
• W1965152316 hasConceptScore W1965152316C170493617 @default.
• W1965152316 hasConceptScore W1965152316C181199279 @default.
• W1965152316 hasConceptScore W1965152316C182220744 @default.
• W1965152316 hasConceptScore W1965152316C185592680 @default.
• W1965152316 hasConceptScore W1965152316C24998067 @default.
• W1965152316 hasConceptScore W1965152316C2775894120 @default.
• W1965152316 hasConceptScore W1965152316C2777515746 @default.
• W1965152316 hasConceptScore W1965152316C2777597313 @default.
• W1965152316 hasConceptScore W1965152316C2777803847 @default.
• W1965152316 hasConceptScore W1965152316C2779276759 @default.
• W1965152316 hasConceptScore W1965152316C2780090379 @default.
• W1965152316 hasConceptScore W1965152316C2780910648 @default.
• W1965152316 hasConceptScore W1965152316C2781063702 @default.
• W1965152316 hasConceptScore W1965152316C55493867 @default.
• W1965152316 hasConceptScore W1965152316C71315377 @default.
• W1965152316 hasConceptScore W1965152316C71924100 @default.
• W1965152316 hasConceptScore W1965152316C86803240 @default.
• W1965152316 hasIssue "22" @default.
• W1965152316 hasLocation W19651523161 @default.
• W1965152316 hasOpenAccess W1965152316 @default.
• W1965152316 hasPrimaryLocation W19651523161 @default.
• W1965152316 hasRelatedWork W1965217754 @default.
• W1965152316 hasRelatedWork W1975696001 @default.
• W1965152316 hasRelatedWork W1987006264 @default.
• W1965152316 hasRelatedWork W2007885146 @default.
• W1965152316 hasRelatedWork W2008261372 @default.

• next